The present invention relates to the use of control compositions and kits comprising such to evaluate and monitor the consistency of assays utilized to determine parathyroid hormone levels.

 
Web www.patentalert.com

< Enhanced oral and transcompartmental delivery of therapeutic or diagnostic agents

< Use of A33 antigens and JAM-IT

> Histone demethylation mediated by the nuclear amine oxidase homolog LSD1

> ApO2 ligand/TRAIL formulations
~ 00618